Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP899040.RAhf1k0fti-w_vMpuUMW5r47cKS42mS0UO0zh6PHfJ2x4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP899040.RAhf1k0fti-w_vMpuUMW5r47cKS42mS0UO0zh6PHfJ2x4130_assertion type Assertion NP899040.RAhf1k0fti-w_vMpuUMW5r47cKS42mS0UO0zh6PHfJ2x4130_head.
- NP899040.RAhf1k0fti-w_vMpuUMW5r47cKS42mS0UO0zh6PHfJ2x4130_assertion description "[Interestingly, HDAC1 association with Sp1 and with the P-Rex1 promoter were much weaker in metastatic prostate cancer PC-3 cells than in non-metastatic prostate cancer cells, and HDAC inhibitors only had very modest stimulatory effects on P-Rex1 promoter activity and P-Rex1 expression in PC-3 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899040.RAhf1k0fti-w_vMpuUMW5r47cKS42mS0UO0zh6PHfJ2x4130_provenance.
- NP899040.RAhf1k0fti-w_vMpuUMW5r47cKS42mS0UO0zh6PHfJ2x4130_assertion evidence source_evidence_literature NP899040.RAhf1k0fti-w_vMpuUMW5r47cKS42mS0UO0zh6PHfJ2x4130_provenance.
- NP899040.RAhf1k0fti-w_vMpuUMW5r47cKS42mS0UO0zh6PHfJ2x4130_assertion SIO_000772 21636851 NP899040.RAhf1k0fti-w_vMpuUMW5r47cKS42mS0UO0zh6PHfJ2x4130_provenance.
- NP899040.RAhf1k0fti-w_vMpuUMW5r47cKS42mS0UO0zh6PHfJ2x4130_assertion wasDerivedFrom befree-2016 NP899040.RAhf1k0fti-w_vMpuUMW5r47cKS42mS0UO0zh6PHfJ2x4130_provenance.
- NP899040.RAhf1k0fti-w_vMpuUMW5r47cKS42mS0UO0zh6PHfJ2x4130_assertion wasGeneratedBy ECO_0000203 NP899040.RAhf1k0fti-w_vMpuUMW5r47cKS42mS0UO0zh6PHfJ2x4130_provenance.